Pathways of Tennessee Inc Substance Abuse Treatment Division
-
Services:
- Comprehensive substance use assessment
- Screening for substance use
- Comprehensive mental health assessment
- Screening for tobacco use
- Interim services for clients
- Screening for mental disorders
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
- Clients with co-occurring mental and substance use disorders
- Treatment for gambling disorder
- Treatment for other addiction disorder
- In-network prescribing entity
- Vaping not permitted
- Mentoring/peer support
- Employment counseling or training
- Housing services
- Recovery coach
- Buprenorphine without naloxone
- Acamprosate (Campral®)
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Nicotine replacement
- Disulfiram
- Buprenorphine with naloxone
- Naltrexone (oral)
- Payment assistance (check with facility for details)
- Sliding fee scale (fee is based on income and other factors)
- Children/Adolescents
- Adults
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Substance use treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- SAMHSA funding/block grants
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Medicaid
- Medicare
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Smoking not permitted
- Transportation assistance
- Suicide prevention services
- Mental health services
- Case management service
- Social skills development
- Individual counseling
- Family counseling
- Group counseling
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Hospital inpatient/24-hour hospital inpatient
- Intensive outpatient treatment
- Hospital inpatient detoxification
- Regular outpatient treatment
- Outpatient
- Buprenorphine maintenance
- Buprenorphine detoxification
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Does not treat opioid use disorders
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- STD testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- TB screening
- Methamphetamines detoxification
- Alcohol Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Benzodiazepines Detoxification
- Female
- Male
- State mental health department
- The Joint Commission
- State Substance use treatment agency
- Sign language services for the deaf and hard of hearing
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Motivational interviewing
- Anger management
- Cognitive behavioral therapy
- Relapse prevention
- Private non-profit organization
Assessment/Pre-treatment
Transitional Services
Special Programs/Groups Offered
Other Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Vaping Policy
Recovery Support Services
Pharmacotherapies
Payment Assistance Available
Age Groups Accepted
Type of Alcohol Use Disorder Treatment
Type of Care
Payment/Insurance/Funding Accepted
Facility Smoking Policy
Ancillary Services
Education and Counseling Services
Opioid Medications used in Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Opioid Treatment
Testing
Detoxification (medical withdrawal) Services
Gender Accepted
License/Certification/Accreditation
Language Services
Treatment Approaches
Facility Operation (e.g., Private, Public)